Yang, C., LaBaff, A., Wei, Y., Nie, L., Xia, W., Huo, L., . . . Hung, M. (2015). Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers. Am J Transl Res.
Citação norma ChicagoYang, Cheng-Chieh, et al. "Phosphorylation of EZH2 At T416 By CDK2 Contributes to the Malignancy of Triple Negative Breast Cancers." Am J Transl Res 2015.
Citação norma MLAYang, Cheng-Chieh, et al. "Phosphorylation of EZH2 At T416 By CDK2 Contributes to the Malignancy of Triple Negative Breast Cancers." Am J Transl Res 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.